Researcher.Life Logo

Der Urologe : Impact Factor & More

eISSN: 1433-0563pISSN: 0340-2592

Key Metrics

CiteScore
0.9
SNIP
0.3
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Der Urologe

Der Urologe Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher Springer Nature

Planning to publish in Der Urologe ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Der Urologe

Reassessing androgen deprivation therapy (ADT) in older men with advanced prostate cancer: when to use, when to discontinue, and role as monotherapy?
  • 19 May 2026
  • Urologie (Heidelberg, Germany)
Artificial intelligence in daily urological care: results of the AI barometer
  • 19 May 2026
  • Urologie (Heidelberg, Germany)
Management of recurrent urolithiasis: indications for therapy escalation and discontinuation
  • 19 May 2026
  • Urologie (Heidelberg, Germany)
Non-muscle-invasive urothelial carcinoma of the bladder: time for ade-escalation of treatment and aftercare
  • 18 May 2026
  • Urologie (Heidelberg, Germany)
Oligometastatic hormone-sensitive prostate cancer: when can less be more?
  • 18 May 2026
  • Urologie (Heidelberg, Germany)
Clinical and practical aspects of multidrug-resistant pathogens
  • 18 May 2026
  • Urologie (Heidelberg, Germany)
Reassessing androgen deprivation therapy (ADT) in older men with advanced prostate cancer: when to use, when to discontinue, and role as monotherapy?
  • 19 May 2026
  • Urologie (Heidelberg, Germany)
Artificial intelligence in daily urological care: results of the AI barometer
  • 19 May 2026
  • Urologie (Heidelberg, Germany)
Management of recurrent urolithiasis: indications for therapy escalation and discontinuation
  • 19 May 2026
  • Urologie (Heidelberg, Germany)
Non-muscle-invasive urothelial carcinoma of the bladder: time for ade-escalation of treatment and aftercare
  • 18 May 2026
  • Urologie (Heidelberg, Germany)
Oligometastatic hormone-sensitive prostate cancer: when can less be more?
  • 18 May 2026
  • Urologie (Heidelberg, Germany)
Clinical and practical aspects of multidrug-resistant pathogens
  • 18 May 2026
  • Urologie (Heidelberg, Germany)

FAQs on Der Urologe